-
-
-
-
-
-
-
INmune Bio, Inc. CEO, Raymond J. Tesi, MD, to Participate in Two Upcoming Panels on Alzheimer's Disease
-
-
-
-
-
-
-
Correction: INmune Bio, Inc. Announces Closing of $25 Million Public Offering of Common Stock Including Full Exercise of Underwriters’ Over-Allotment Option
-
-
-
-
-
-
-
INmune Bio, Inc. Announces Proposed Public Offering of Common Stock
-
10,179 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

